Clinical trial
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 3, 2019
- Completion date
- September 30, 2023
- Enrollment
- 238 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer